Literature DB >> 23385651

The low-density lipoprotein receptor-related protein 1 in inflammation.

Petra May1.   

Abstract

PURPOSE OF REVIEW: The lipoprotein receptor low-density lipoprotein receptor-related protein 1 (LRP1) functions both in endocytosis and in signal transduction. Recently, it has become clear that LRP1 modulates the inflammatory response to various noxious stimuli. This review is to summarize our current knowledge about the role of LRP1 in inflammation. RECENT
FINDINGS: LRP1 modulates the inflammatory response in different organs and under various pathophysiological conditions. Both direct regulation of inflammatory signaling through the binding of extracellular messengers or intracellular signaling molecules and indirect modulation through the interaction with other transmembrane receptors or the endocytosis of extracellular factors have been described. Regulation by LRP1 effects cytokine secretion, phagocytosis and migration of cells of the immune system.
SUMMARY: In recent years, LRP1 emerged as an important regulator of the inflammatory response. Owing to the ubiquitous expression of this receptor, this function is of importance in different organs and under various pathophysiological conditions in which inflammation contributes to disease, that is atherosclerosis, neurodegeneration and organ fibrosis, for example of the lung or liver.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23385651     DOI: 10.1097/MOL.0b013e32835e809c

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  20 in total

1.  Low-density lipoprotein receptor-related protein 1 attenuates house dust mite-induced eosinophilic airway inflammation by suppressing dendritic cell-mediated adaptive immune responses.

Authors:  Amarjit Mishra; Xianglan Yao; Ankit Saxena; Elizabeth M Gordon; Maryann Kaler; Rosemarie A Cuento; Amisha V Barochia; Pradeep K Dagur; J Philip McCoy; Karen J Keeran; Kenneth R Jeffries; Xuan Qu; Zu-Xi Yu; Stewart J Levine
Journal:  J Allergy Clin Immunol       Date:  2017-12-21       Impact factor: 10.793

2.  Macrophage-derived apoESendai suppresses atherosclerosis while causing lipoprotein glomerulopathy in hyperlipidemic mice.

Authors:  Hagai Tavori; Daping Fan; Ilaria Giunzioni; Lin Zhu; MacRae F Linton; Agnes B Fogo; Sergio Fazio
Journal:  J Lipid Res       Date:  2014-09-02       Impact factor: 5.922

3.  Celastrol-loaded PEG-b-PPS nanocarriers as an anti-inflammatory treatment for atherosclerosis.

Authors:  Sean D Allen; Yu-Gang Liu; Taehyeung Kim; Sharan Bobbala; Sijia Yi; Xiaohan Zhang; Jaehyuk Choi; Evan A Scott
Journal:  Biomater Sci       Date:  2019-01-29       Impact factor: 6.843

4.  Glioma-derived plasminogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1 positive mast cells.

Authors:  Ananya Roy; Antoine Coum; Voichita D Marinescu; Jelena Põlajeva; Anja Smits; Sven Nelander; Lene Uhrbom; Bengt Westermark; Karin Forsberg-Nilsson; Fredrik Pontén; Elena Tchougounova
Journal:  Oncotarget       Date:  2015-09-15

5.  Arnica montana Stimulates Extracellular Matrix Gene Expression in a Macrophage Cell Line Differentiated to Wound-Healing Phenotype.

Authors:  Marta Marzotto; Clara Bonafini; Debora Olioso; Anna Baruzzi; Laura Bettinetti; Francesca Di Leva; Elisabetta Galbiati; Paolo Bellavite
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

6.  Shunts, channels and lipoprotein endosomal traffic: a new model of cholesterol homeostasis in the hepatocyte.

Authors:  Robert Scott Kiss; Allan Sniderman
Journal:  J Biomed Res       Date:  2017-01-19

Review 7.  PCSK9 targets important for lipid metabolism.

Authors:  Rainer Schulz; Klaus-Dieter Schlüter
Journal:  Clin Res Cardiol Suppl       Date:  2017-03

8.  Alpha-2-macroglobulin loaded microcapsules enhance human leukocyte functions and innate immune response.

Authors:  Donata Federici Canova; Anton M Pavlov; Lucy V Norling; Thomas Gobbetti; Sandra Brunelleschi; Pauline Le Fauder; Nicolas Cenac; Gleb B Sukhorukov; Mauro Perretti
Journal:  J Control Release       Date:  2015-09-16       Impact factor: 9.776

9.  Soluble LRP1 is an independent biomarker of epicardial fat volume in patients with type 1 diabetes mellitus.

Authors:  David de Gonzalo-Calvo; Cristina Colom; David Vilades; Andrea Rivas-Urbina; Abdel-Hakim Moustafa; Montserrat Pérez-Cuellar; Jose Luis Sánchez-Quesada; Antonio Pérez; Vicenta LLorente-Cortes
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

Review 10.  Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease.

Authors:  Simon Glerup; Rainer Schulz; Ulrich Laufs; Klaus-Dieter Schlüter
Journal:  Basic Res Cardiol       Date:  2017-04-24       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.